about
Controlling dengue with vaccines in ThailandMechanism and significance of cell type-dependent neutralization of flavivirusesSpatial and temporal country-wide survey of temephos resistance in Brazilian populations of Aedes aegyptiThe global distribution and burden of dengueThe Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseVaccines for the 21st centuryMouse models to study dengue virus immunology and pathogenesisUnderstanding the dengue viruses and progress towards their controlDengue structure differs at the temperatures of its human and mosquito hostsVaccines and immunization strategies for dengue preventionEstimation of Aedes aegypti (Diptera: Culicidae) population size and adult male survival in an urban area in PanamaSpatio-temporal distribution of dengue and lymphatic filariasis vectors along an altitudinal transect in Central NepalRisk factors for the presence of chikungunya and dengue vectors (Aedes aegypti and Aedes albopictus), their altitudinal distribution and climatic determinants of their abundance in central Nepal.Current progress in dengue vaccinesDengue: challenges for policy makers and vaccine developers.Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.Knowledge, attitude and practice regarding dengue fever among the healthy population of highland and lowland communities in central NepalQTL mapping of genome regions controlling temephos resistance in larvae of the mosquito Aedes aegypti.Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.Dengue virus type 3 adaptive changes during epidemics in São Jose de Rio Preto, Brazil, 2006-2007.Role of humoral versus cellular responses induced by a protective dengue vaccine candidate.CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.Integrating Transgenic Vector Manipulation with Clinical Interventions to Manage Vector-Borne Diseases.Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysisA household-based survey of knowledge, attitudes and practices towards dengue fever among local urban communities in Taiz Governorate, YemenHuman monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics.Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes.Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection.Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profilesThree-Month Real-Time Dengue Forecast Models: An Early Warning System for Outbreak Alerts and Policy Decision Support in Singapore.A threshold analysis of dengue transmission in terms of weather variables and imported dengue cases in AustraliaCountry- and age-specific optimal allocation of dengue vaccinesConformational changes in intact dengue virus reveal serotype-specific expansion.Combining contact tracing with targeted indoor residual spraying significantly reduces dengue transmission.Genetic control of Aedes mosquitoesFight against dengue in India: progresses and challenges.Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection.Dengue human infection models supporting drug development.Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.
P2860
Q21562250-1E035E3D-2F78-4A2A-95ED-0937AC209521Q23032973-5513A21E-3BD5-4D02-B19B-F0DC9DDA8FC8Q24282590-92066644-80F0-43C9-8518-F3204F9DB448Q24628768-F0C6FF0F-08CD-496C-BAF8-3AC3C41AB0A3Q26995782-97C2F50F-3CC2-47F5-B3F0-F6486F2A5A79Q27007529-F9FC5A0D-F0BC-4356-AF12-D13ED8924AFBQ27010151-201DAB51-4C68-415F-9748-568AC913534DQ27011587-91D25BE0-D9AE-49E0-A2CE-6C517E98BB8DQ27677270-0D6328C5-94C3-4C94-BAA6-B2E0B13EE8D9Q28077521-DB430F46-B905-422B-B296-A618FD260F41Q28652179-BD7B06F4-2142-4D68-809B-0663B39A7AAEQ28656185-94D1A67A-217A-45E9-8AD9-C74F073EA762Q30910854-66B6E9AA-E86E-44FB-90B8-F1EA2DE22ECEQ33408300-A68B62B8-7EBA-4218-9789-5C5263A6F3A0Q33624327-360D6479-9651-4FFE-8FCA-DE3B386149EDQ33743890-1B3ABB5E-EC6A-4B86-A0FB-BBBD8333EF73Q33875200-BE2509D6-FD81-463F-A385-A846B4575B46Q34351411-75095536-36B8-4AAA-B74D-A58CD695B189Q34522384-EFEE445C-E0D1-4B1E-8AB8-60F700762DFBQ34718200-3EA28130-2ADF-48E2-B17F-40DDA6AF9482Q35034240-60C32C48-F77E-4588-A520-69A694D8FB7DQ35760439-FA46D2F1-8947-4080-A4B2-B7AD35CBFB88Q35952111-D7E2F1D6-D89A-47CA-A624-059ED4D12718Q36082908-E130DBBE-EC9E-4C12-9F1B-5481D2740E4DQ36158002-3298165B-C85C-477D-B2A8-87F3FD34B278Q36846290-CFF2661D-DF7F-48B0-A4C3-AF5C4A92B4E7Q36895627-D4ACE476-0FF0-4196-BE51-1FD91E7CD1C5Q36992653-6BA460E1-1F32-426D-955E-D3ACFF68F477Q37123259-A4C73ED9-0BE0-404A-9A24-70DEDD06AEDFQ37184768-10E18FF0-76A4-43C8-A9FD-4FC7FEEF7BC9Q37230310-CEF387B0-0A0A-4D16-AF59-635B90956BC4Q37433793-7D583603-B33B-4DE6-A2F2-4489AE7C885CQ37625631-AFECFDEB-8E50-426A-B8E4-B36324436C10Q37642687-A235C0CC-0B5B-4CBB-B634-D1DC1BCE6550Q37650260-6DAFFA2D-DD1F-4F24-82C2-479DE94400D5Q37726480-F8390ED8-42EB-4D5F-8A38-1DEE232EB0E7Q38086052-FECA2594-A89C-4889-94CC-A6D62A1A40E8Q38248452-D119F093-CBF3-4C3B-ACF0-F3E17B06AD80Q39590469-F01E6744-DE4A-444D-BA3B-B804977F2164Q40040450-079AFE5E-B504-45C2-8C17-1587223B1600
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dengue vaccine development: a 75% solution?
@en
type
label
Dengue vaccine development: a 75% solution?
@en
prefLabel
Dengue vaccine development: a 75% solution?
@en
P1433
P1476
Dengue vaccine development: a 75% solution?
@en
P2093
Scott B Halstead
P304
P356
10.1016/S0140-6736(12)61510-4
P407
P577
2012-09-11T00:00:00Z